Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults

Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumoc...

Full description

Saved in:
Bibliographic Details
Published inMedical microbiology and immunology Vol. 202; no. 4; pp. 285 - 294
Main Authors Rose, M. A., Buess, J., Ventur, Y., Zielen, S., Herrmann, E., Schulze, J., Schubert, R.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2013
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0300-8584
1432-1831
1432-1831
DOI10.1007/s00430-013-0292-3

Cover

Loading…
Abstract Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG 2 antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8–12 years. In parallel, IgG 2 antibodies increased from 20.7 % (0.5–1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson’s coefficient r  = 0.4455; p  = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG 2 assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing.
AbstractList Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG2 antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8-12 years. In parallel, IgG2 antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG2 assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing.Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG2 antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8-12 years. In parallel, IgG2 antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG2 assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing.
Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG2 antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8-12 years. In parallel, IgG2 antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG2 assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing.
Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG^sub 2^ antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 [mu]g/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 [mu]g/ml) at age 8-12 years. In parallel, IgG^sub 2^ antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG^sub 2^ assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing.[PUBLICATION ABSTRACT]
Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG sub(2) antibodies by EIA. In vaccine-naive healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 mu g/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 mu g/ml) at age 8-12 years. In parallel, IgG sub(2) antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG sub(2) assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing.
Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG 2 antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8–12 years. In parallel, IgG 2 antibodies increased from 20.7 % (0.5–1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson’s coefficient r  = 0.4455; p  = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG 2 assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing.
Author Buess, J.
Rose, M. A.
Schulze, J.
Zielen, S.
Ventur, Y.
Schubert, R.
Herrmann, E.
Author_xml – sequence: 1
  givenname: M. A.
  surname: Rose
  fullname: Rose, M. A.
  email: Markus.Rose@kgu.de
  organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University
– sequence: 2
  givenname: J.
  surname: Buess
  fullname: Buess, J.
  organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University
– sequence: 3
  givenname: Y.
  surname: Ventur
  fullname: Ventur, Y.
  organization: The Binding Site GmbH
– sequence: 4
  givenname: S.
  surname: Zielen
  fullname: Zielen, S.
  organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University
– sequence: 5
  givenname: E.
  surname: Herrmann
  fullname: Herrmann, E.
  organization: Institute of Biostatistics and Mathematical Modelling, Goethe-University
– sequence: 6
  givenname: J.
  surname: Schulze
  fullname: Schulze, J.
  organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University
– sequence: 7
  givenname: R.
  surname: Schubert
  fullname: Schubert, R.
  organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23529214$$D View this record in MEDLINE/PubMed
BookMark eNqNks9q3DAQxkVJaTZpH6CXIuglObgdSbalPZaQfxAIlNyNLI92FWRpK9mFfZC-b7W7SSmBlpxGgt838w3fnJCjEAMS8pHBFwYgv2aAWkAFTFTAl7wSb8iC1YJXTAl2RBYgACrVqPqYnOT8CMBky-EdOeaiKTyrF-TXd7SYMBikSYcVZqrDQM08RWupx5_oM42WbgLOYzTRGO0LMbk-Dlu68rEv_4xpHqnOWW8zPbtdXe97lMrP96-8QeOsM89CV6a4QNeo_bTeUrN2figW9qweZj_l9-St1T7jh6d6Sh6uLh8ubqq7--vbi293lamhmSqheA2KoS3raNMvBRcWjJSWFZ-NbNpWGdloUL3VjelbrWpcDmLQ2Es5oDglZ4e2mxR_zJinbnTZoPc6YJxzx2ougXEmxCtQJhuuWN0W9PML9DHOKZQ99hS0TKmmUJ-eqLkfceg2yY06bbvnaArADoBJMeeE9g_CoNvF3x3i70r83S7-budSvtAYN-nJxTAl7fx_lfygzGVKuYP0l-l_in4DCCnDVg
CitedBy_id crossref_primary_10_1016_j_jim_2020_112846
crossref_primary_10_1016_j_vaccine_2019_01_035
crossref_primary_10_1016_j_vaccine_2020_02_088
crossref_primary_10_1007_s15010_023_02054_3
crossref_primary_10_1542_peds_2014_3907
crossref_primary_10_1007_s00430_014_0346_1
crossref_primary_10_1093_ofid_ofad497
crossref_primary_10_3389_fimmu_2019_02496
crossref_primary_10_1016_j_clim_2020_108491
crossref_primary_10_1002_cam4_2253
crossref_primary_10_3389_fimmu_2017_01862
crossref_primary_10_1007_s00112_022_01432_9
crossref_primary_10_1007_s12016_021_08860_7
crossref_primary_10_3109_10408444_2015_1122573
crossref_primary_10_1080_15321819_2017_1340897
Cites_doi 10.1016/j.vaccine.2007.01.119
10.1016/0022-1759(96)00033-6
10.1111/j.1365-2141.2009.07903.x
10.1097/01.inf.0000115737.35353.55
10.1097/01.mlg.0000171016.82850.41
10.1111/j.1365-2249.2006.03138.x
10.1016/S0264-410X(98)00475-7
10.1086/431679
10.1073/pnas.230417497
10.1086/513199
10.1086/422395
10.1086/422531
10.1038/sj.bmt.1701967
10.1111/j.1365-2249.2006.03242.x
10.1016/0091-6749(93)90303-W
10.1016/S0091-6749(96)80078-9
10.1046/j.1365-2249.2003.02232.x
10.1046/j.1440-1754.2001.00687.x
10.1016/S0091-6749(98)70089-2
10.1016/j.vaccine.2009.06.054
10.1128/CDLI.12.10.1216-1222.2005
10.1128/CDLI.6.3.446-446.1999
10.1128/CDLI.10.2.202-207.2003
10.1128/CDLI.8.2.266-272.2001
ContentType Journal Article
Copyright Springer-Verlag Berlin Heidelberg 2013
Copyright_xml – notice: Springer-Verlag Berlin Heidelberg 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7U9
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7N
M7P
MBDVC
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
7QL
C1K
DOI 10.1007/s00430-013-0292-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE - Academic
MEDLINE
Research Library Prep
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1432-1831
EndPage 294
ExternalDocumentID 3033678161
23529214
10_1007_s00430_013_0292_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5VS
67N
67Z
6NX
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EDH
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GUQSH
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LK8
LLZTM
M1P
M2O
M4Y
M7P
MA-
MM.
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
PZZ
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
X7M
YLTOR
Z45
Z7U
Z87
Z8O
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7U9
7XB
8FD
8FK
ABRTQ
FR3
H94
K9.
M7N
MBDVC
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
PUEGO
Q9U
RC3
7X8
7QL
C1K
ID FETCH-LOGICAL-c405t-3824081ef352acb9323f0c77f1cca575668c75a08bfa5cb6a84e9d3daeb77de3
IEDL.DBID AGYKE
ISSN 0300-8584
1432-1831
IngestDate Fri Sep 05 08:56:06 EDT 2025
Fri Sep 05 07:13:07 EDT 2025
Sat Aug 23 13:35:16 EDT 2025
Wed Feb 19 02:16:14 EST 2025
Thu Apr 24 22:58:02 EDT 2025
Tue Jul 01 00:53:47 EDT 2025
Fri Feb 21 02:35:43 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Screening
Cutoff levels
Pneumococcal antibodies
Reference values
Immunodeficiency
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c405t-3824081ef352acb9323f0c77f1cca575668c75a08bfa5cb6a84e9d3daeb77de3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 23529214
PQID 1417061885
PQPubID 47200
PageCount 10
ParticipantIDs proquest_miscellaneous_1427012133
proquest_miscellaneous_1417528146
proquest_journals_1417061885
pubmed_primary_23529214
crossref_primary_10_1007_s00430_013_0292_3
crossref_citationtrail_10_1007_s00430_013_0292_3
springer_journals_10_1007_s00430_013_0292_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20130800
2013-8-00
2013-Aug
20130801
PublicationDateYYYYMMDD 2013-08-01
PublicationDate_xml – month: 8
  year: 2013
  text: 20130800
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Berlin
PublicationTitle Medical microbiology and immunology
PublicationTitleAbbrev Med Microbiol Immunol
PublicationTitleAlternate Med Microbiol Immunol
PublicationYear 2013
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Madore, Quataert, Mariani, Berbers (CR6) 1999; 6
Ochsenbein, Pinschewer, Sierro, Horvath, Hengartner, Zinkernagel (CR11) 2000; 97
Lehrnbecher, Schubert, Behl, Koenig, Rose, Koehl (CR26) 2009; 147
Sanders, Rijkers, Kuis (CR8) 1993; 91
Rose, Schubert, Strnad, Zielen (CR25) 2005; 12
Hey, Rose, Kujumdshiev, Gstoettner, Schubert, Zielen (CR16) 2005; 115
Boyle, Le, Balloch, Tang (CR24) 2006; 146
Siber, Chang, Baker, Fernsten, O’Brien, Santosham, Klugman (CR7) 2007; 25
Soininen, Seppala, Nieminen, Eskola, Kayhty (CR23) 1999; 17
Zielen, Bröker, Strnad, Schwenen, Schön, Gottwald, Hofmann (CR3) 1996; 193
Schubert, Reichenbach, Rose, Zielen (CR9) 2004; 23
Millar, O’Brien, Bronsdon, Madore, Hackell, Reid, Santosham (CR21) 2007; 44
Balmer, North, Baxter, Stanford, Melegaro, Kaczmarski, Miller, Borrow (CR18) 2003; 133
de Vries (CR1) 2005; 145
Rose, Gruendler, Schubert, Kitz, Schulze, Rosewich, Zielen (CR27) 2009; 27
Lau, Bettelheim, Patel (CR15) 1988; 101
Rose, Hey, Kujumdshiew, Gall, Schubert, Zielen (CR17) 2004; 190
CR5
Dagan, Givon-Lavi, Fraser, Lipsitch, Siber, Kohberger (CR20) 2005; 192
Akikusa, Kemp (CR10) 2001; 37
Parkkali, Kayhty, Anttila, Ruutu, Wuorimaa, Soininen (CR22) 1999; 24
Sorensen, Leiva, Javier, Sacerdote, Bradford, Butler, Giangrosso, Moore (CR13) 1998; 102
Jokinen, Ahman, Kilpi, Makela, Kayhty (CR19) 2004; 190
Concepcion, Frasch (CR4) 2001; 8
Schauer, Stemberg, Rieger, Büttner, Borte, Schubert (CR2) 2003; 10
Peset Llopis, Harms, Hardonk, Timens (CR12) 1996; 97
Soininen, Karpala, Wahlman, Lehtonen, Kayhty (CR14) 2002; 9
EAM Sanders (292_CR8) 1993; 91
RJ Boyle (292_CR24) 2006; 146
MA Rose (292_CR27) 2009; 27
P Balmer (292_CR18) 2003; 133
JD Akikusa (292_CR10) 2001; 37
EV Millar (292_CR21) 2007; 44
MA Rose (292_CR17) 2004; 190
S Zielen (292_CR3) 1996; 193
R Schubert (292_CR9) 2004; 23
292_CR5
RC Lau (292_CR15) 1988; 101
T Parkkali (292_CR22) 1999; 24
T Lehrnbecher (292_CR26) 2009; 147
JT Jokinen (292_CR19) 2004; 190
E Vries de (292_CR1) 2005; 145
AF Ochsenbein (292_CR11) 2000; 97
U Schauer (292_CR2) 2003; 10
MA Rose (292_CR25) 2005; 12
C Hey (292_CR16) 2005; 115
DV Madore (292_CR6) 1999; 6
NF Concepcion (292_CR4) 2001; 8
RU Sorensen (292_CR13) 1998; 102
GR Siber (292_CR7) 2007; 25
A Soininen (292_CR14) 2002; 9
A Soininen (292_CR23) 1999; 17
R Dagan (292_CR20) 2005; 192
MJ Peset Llopis (292_CR12) 1996; 97
15243931 - J Infect Dis. 2004 Aug 1;190(3):551-7
11532059 - J Paediatr Child Health. 2001 Aug;37(4):382-7
16879238 - Clin Exp Immunol. 2006 Aug;145(2):204-14
17368878 - Vaccine. 2007 May 10;25(19):3816-26
8655878 - J Allergy Clin Immunol. 1996 Apr;97(4):1015-24
10217586 - Vaccine. 1999 Apr 9;17(15-16):1889-97
19764991 - Br J Haematol. 2009 Dec;147(5):700-5
8423268 - J Allergy Clin Immunol. 1993 Jan;91(1 Pt 1):110-9
17100769 - Clin Exp Immunol. 2006 Dec;146(3):486-92
15995949 - J Infect Dis. 2005 Aug 1;192(3):367-76
12626443 - Clin Diagn Lab Immunol. 2003 Mar;10(2):202-7
10490735 - Bone Marrow Transplant. 1999 Sep;24(6):671-8
11069289 - Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13263-8
17407035 - Clin Infect Dis. 2007 May 1;44(9):1173-9
15014308 - Pediatr Infect Dis J. 2004 Mar;23(3):269-70
10490332 - Clin Diagn Lab Immunol. 1999 May;6(3):446
8690926 - J Immunol Methods. 1996 Jun 14;193(1):1-7
15243930 - J Infect Dis. 2004 Aug 1;190(3):545-50
3194078 - N Z Med J. 1988 Nov 23;101(858):797-800
12204955 - Clin Diagn Lab Immunol. 2002 Sep;9(5):1032-8
12930362 - Clin Exp Immunol. 2003 Sep;133(3):364-9
19576944 - Vaccine. 2009 Aug 20;27(38):5259-64
9723664 - J Allergy Clin Immunol. 1998 Aug;102(2):215-21
16210486 - Clin Diagn Lab Immunol. 2005 Oct;12(10):1216-22
16148699 - Laryngoscope. 2005 Sep;115(9):1586-90
11238206 - Clin Diagn Lab Immunol. 2001 Mar;8(2):266-72
References_xml – volume: 25
  start-page: 3816
  issue: 19
  year: 2007
  end-page: 3826
  ident: CR7
  article-title: Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.01.119
– volume: 193
  start-page: 1
  issue: 1
  year: 1996
  end-page: 7
  ident: CR3
  article-title: Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA-Plates
  publication-title: J Immunol Methods
  doi: 10.1016/0022-1759(96)00033-6
– volume: 12
  start-page: 1216
  issue: 10
  year: 2005
  end-page: 1222
  ident: CR25
  article-title: Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine
  publication-title: Clin Diagn Lab Immunol
– volume: 147
  start-page: 700
  issue: 5
  year: 2009
  end-page: 705
  ident: CR26
  article-title: Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2009.07903.x
– volume: 23
  start-page: 269
  issue: 3
  year: 2004
  end-page: 270
  ident: CR9
  article-title: Immunogenicity of the 7-valent pneumococcal conjugate vaccine in patients with ataxia telangiectasia
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/01.inf.0000115737.35353.55
– volume: 115
  start-page: 1586
  issue: 9
  year: 2005
  end-page: 1590
  ident: CR16
  article-title: Does the 23-valent pneumococcal vaccine protect cochlear implant recipients?
  publication-title: Laryngoscope
  doi: 10.1097/01.mlg.0000171016.82850.41
– volume: 145
  start-page: 204
  year: 2005
  end-page: 214
  ident: CR1
  article-title: Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2006.03138.x
– volume: 8
  start-page: 266
  year: 2001
  end-page: 272
  ident: CR4
  article-title: Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay
  publication-title: Clin Diagn Lab Immunol
– volume: 10
  start-page: 202
  issue: 2
  year: 2003
  end-page: 207
  ident: CR2
  article-title: Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type B, and pneumococcal capsular polysaccharide in healthy children and adults
  publication-title: Clin Diagn Lab Immunol
– volume: 17
  start-page: 1889
  year: 1999
  end-page: 1897
  ident: CR23
  article-title: IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(98)00475-7
– volume: 192
  start-page: 367
  issue: 3
  year: 2005
  end-page: 376
  ident: CR20
  article-title: Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus
  publication-title: J Infect Dis
  doi: 10.1086/431679
– volume: 97
  start-page: 13263
  year: 2000
  end-page: 13268
  ident: CR11
  article-title: Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.230417497
– volume: 9
  start-page: 1032
  year: 2002
  end-page: 1038
  ident: CR14
  article-title: Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children
  publication-title: Clin Diagn Lab Immunol
– volume: 44
  start-page: 1173
  issue: 9
  year: 2007
  end-page: 1179
  ident: CR21
  article-title: Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine
  publication-title: Clin Infect Dis
  doi: 10.1086/513199
– volume: 190
  start-page: 551
  year: 2004
  end-page: 557
  ident: CR17
  article-title: Immunogenicity of pneumococcal vaccination in patients with cochlear implants
  publication-title: J Infect Dis
  doi: 10.1086/422395
– volume: 190
  start-page: 545
  year: 2004
  end-page: 550
  ident: CR19
  article-title: Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media
  publication-title: J Infect Dis
  doi: 10.1086/422531
– volume: 24
  start-page: 671
  year: 1999
  end-page: 678
  ident: CR22
  article-title: IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines
  publication-title: Bone Marrow Transplant
  doi: 10.1038/sj.bmt.1701967
– volume: 146
  start-page: 486
  year: 2006
  end-page: 492
  ident: CR24
  article-title: The clinical syndrome of specific antibody deficiency in children
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2006.03242.x
– volume: 91
  start-page: 110
  year: 1993
  end-page: 119
  ident: CR8
  article-title: Defective anti-pneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/0091-6749(93)90303-W
– volume: 97
  start-page: 1015
  year: 1996
  end-page: 1024
  ident: CR12
  article-title: Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(96)80078-9
– volume: 101
  start-page: 797
  year: 1988
  end-page: 800
  ident: CR15
  article-title: The 1985 national immunization survey: diphtheria, tetanus, and pertussis
  publication-title: NZ Med J
– volume: 6
  start-page: 446
  year: 1999
  ident: CR6
  article-title: Interlaboratory reproducibility of an enzyme-linked immunosorbent assay for quantitation of antibodies for Haemophilus influenzae type b polysaccharide
  publication-title: Clin Diagn Lab Immunol
– volume: 133
  start-page: 364
  issue: 3
  year: 2003
  end-page: 369
  ident: CR18
  article-title: Measurement and interpretation of pneumococcal IgG levels for clinical management
  publication-title: Clin Exp Immunol
  doi: 10.1046/j.1365-2249.2003.02232.x
– ident: CR5
– volume: 37
  start-page: 382
  year: 2001
  end-page: 387
  ident: CR10
  article-title: Clinical correlates of response to pneumococcal immunization
  publication-title: J Paediatr Child Health
  doi: 10.1046/j.1440-1754.2001.00687.x
– volume: 102
  start-page: 215
  year: 1998
  end-page: 221
  ident: CR13
  article-title: Influence of age on the response to vaccine in patients with recurrent infections and normal immunoglobulin concentrations
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(98)70089-2
– volume: 27
  start-page: 5259
  issue: 38
  year: 2009
  end-page: 5264
  ident: CR27
  article-title: Safety and immunogenicity of sequential pneumococcal immunization in preschool asthmatics
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.06.054
– volume: 24
  start-page: 671
  year: 1999
  ident: 292_CR22
  publication-title: Bone Marrow Transplant
  doi: 10.1038/sj.bmt.1701967
– volume: 37
  start-page: 382
  year: 2001
  ident: 292_CR10
  publication-title: J Paediatr Child Health
  doi: 10.1046/j.1440-1754.2001.00687.x
– volume: 12
  start-page: 1216
  issue: 10
  year: 2005
  ident: 292_CR25
  publication-title: Clin Diagn Lab Immunol
  doi: 10.1128/CDLI.12.10.1216-1222.2005
– volume: 6
  start-page: 446
  year: 1999
  ident: 292_CR6
  publication-title: Clin Diagn Lab Immunol
  doi: 10.1128/CDLI.6.3.446-446.1999
– volume: 190
  start-page: 551
  year: 2004
  ident: 292_CR17
  publication-title: J Infect Dis
  doi: 10.1086/422395
– volume: 23
  start-page: 269
  issue: 3
  year: 2004
  ident: 292_CR9
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/01.inf.0000115737.35353.55
– volume: 133
  start-page: 364
  issue: 3
  year: 2003
  ident: 292_CR18
  publication-title: Clin Exp Immunol
  doi: 10.1046/j.1365-2249.2003.02232.x
– volume: 97
  start-page: 13263
  year: 2000
  ident: 292_CR11
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.230417497
– volume: 10
  start-page: 202
  issue: 2
  year: 2003
  ident: 292_CR2
  publication-title: Clin Diagn Lab Immunol
  doi: 10.1128/CDLI.10.2.202-207.2003
– volume: 145
  start-page: 204
  year: 2005
  ident: 292_CR1
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2006.03138.x
– volume: 190
  start-page: 545
  year: 2004
  ident: 292_CR19
  publication-title: J Infect Dis
  doi: 10.1086/422531
– volume: 102
  start-page: 215
  year: 1998
  ident: 292_CR13
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(98)70089-2
– volume: 193
  start-page: 1
  issue: 1
  year: 1996
  ident: 292_CR3
  publication-title: J Immunol Methods
  doi: 10.1016/0022-1759(96)00033-6
– volume: 8
  start-page: 266
  year: 2001
  ident: 292_CR4
  publication-title: Clin Diagn Lab Immunol
  doi: 10.1128/CDLI.8.2.266-272.2001
– ident: 292_CR5
– volume: 101
  start-page: 797
  year: 1988
  ident: 292_CR15
  publication-title: NZ Med J
– volume: 97
  start-page: 1015
  year: 1996
  ident: 292_CR12
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(96)80078-9
– volume: 192
  start-page: 367
  issue: 3
  year: 2005
  ident: 292_CR20
  publication-title: J Infect Dis
  doi: 10.1086/431679
– volume: 17
  start-page: 1889
  year: 1999
  ident: 292_CR23
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(98)00475-7
– volume: 91
  start-page: 110
  year: 1993
  ident: 292_CR8
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/0091-6749(93)90303-W
– volume: 25
  start-page: 3816
  issue: 19
  year: 2007
  ident: 292_CR7
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.01.119
– volume: 44
  start-page: 1173
  issue: 9
  year: 2007
  ident: 292_CR21
  publication-title: Clin Infect Dis
  doi: 10.1086/513199
– volume: 147
  start-page: 700
  issue: 5
  year: 2009
  ident: 292_CR26
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2009.07903.x
– volume: 9
  start-page: 1032
  year: 2002
  ident: 292_CR14
  publication-title: Clin Diagn Lab Immunol
– volume: 115
  start-page: 1586
  issue: 9
  year: 2005
  ident: 292_CR16
  publication-title: Laryngoscope
  doi: 10.1097/01.mlg.0000171016.82850.41
– volume: 146
  start-page: 486
  year: 2006
  ident: 292_CR24
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2006.03242.x
– volume: 27
  start-page: 5259
  issue: 38
  year: 2009
  ident: 292_CR27
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.06.054
– reference: 15243930 - J Infect Dis. 2004 Aug 1;190(3):545-50
– reference: 10217586 - Vaccine. 1999 Apr 9;17(15-16):1889-97
– reference: 16879238 - Clin Exp Immunol. 2006 Aug;145(2):204-14
– reference: 16210486 - Clin Diagn Lab Immunol. 2005 Oct;12(10):1216-22
– reference: 10490332 - Clin Diagn Lab Immunol. 1999 May;6(3):446
– reference: 11532059 - J Paediatr Child Health. 2001 Aug;37(4):382-7
– reference: 15243931 - J Infect Dis. 2004 Aug 1;190(3):551-7
– reference: 17100769 - Clin Exp Immunol. 2006 Dec;146(3):486-92
– reference: 8690926 - J Immunol Methods. 1996 Jun 14;193(1):1-7
– reference: 8655878 - J Allergy Clin Immunol. 1996 Apr;97(4):1015-24
– reference: 10490735 - Bone Marrow Transplant. 1999 Sep;24(6):671-8
– reference: 12204955 - Clin Diagn Lab Immunol. 2002 Sep;9(5):1032-8
– reference: 17368878 - Vaccine. 2007 May 10;25(19):3816-26
– reference: 15995949 - J Infect Dis. 2005 Aug 1;192(3):367-76
– reference: 3194078 - N Z Med J. 1988 Nov 23;101(858):797-800
– reference: 19576944 - Vaccine. 2009 Aug 20;27(38):5259-64
– reference: 9723664 - J Allergy Clin Immunol. 1998 Aug;102(2):215-21
– reference: 19764991 - Br J Haematol. 2009 Dec;147(5):700-5
– reference: 8423268 - J Allergy Clin Immunol. 1993 Jan;91(1 Pt 1):110-9
– reference: 11238206 - Clin Diagn Lab Immunol. 2001 Mar;8(2):266-72
– reference: 15014308 - Pediatr Infect Dis J. 2004 Mar;23(3):269-70
– reference: 11069289 - Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13263-8
– reference: 12930362 - Clin Exp Immunol. 2003 Sep;133(3):364-9
– reference: 16148699 - Laryngoscope. 2005 Sep;115(9):1586-90
– reference: 17407035 - Clin Infect Dis. 2007 May 1;44(9):1173-9
– reference: 12626443 - Clin Diagn Lab Immunol. 2003 Mar;10(2):202-7
SSID ssj0017620
Score 2.0649796
Snippet Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 285
SubjectTerms Adolescent
Adult
Adults
Age Factors
Antibodies, Bacterial - blood
Biomedical and Life Sciences
Biomedicine
Child
Child, Preschool
Children & youth
Enzyme-Linked Immunosorbent Assay
Female
Health
Healthy Volunteers
Humans
Immunoglobulin G - blood
Immunology
Infant
Male
Medical Microbiology
Middle Aged
Monoclonal antibodies
Original Investigation
Reference Values
Sensitivity and Specificity
Serum - immunology
Streptococcus pneumoniae
Streptococcus pneumoniae - immunology
Virology
Young Adult
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9UwDI9gXJAQ4psHAwWJAx-KSJO0TU4IIcZAgtOQ3mlVmibTpK19rO3h_S37Z2cnbQFNvFNV1W2t2Ens2P6ZkNe8gCmmdGCm4Zop2JCZsZjskNfCCOeUj10UfvwsDn-p7-t8PR249VNa5bwmxoW66RyekX_IFAK9ZFrnHze_GXaNwujq1ELjJrkVoctAn8v14nBlMNF5iiJwpmGnnaOaPIGISkzJwiimEUz-uy9dMzavBUrj_nNwj9ydDEf6KUn6Prnh2wfkTjp1o6mY6CG5XHBj6QVWDfTUtg1149CFQM8wP6inXaCb1o_nHSyFICCgGE7rrtnShA1CQSfHcwo2td329M23k6_xG3A97seaiuO38R4rNDHLaH4dHG562tJUVrmlc414pI0YH_0jcnTw5ejzIZvaLzAHVtzApEb4s8wHsNGsq8HQk4G7sgwZcAdWXlFoV-aW6zrY3NWF1cqbRjbW12XZePmY7LVd658SqhplgiwldmEHD8sar5wLBUffjwdtVoTPY1-5CZocO2ScVQuochRXBeKqUFyVXJF3yyubhMuxi3h_Fmg1TdG--qNQK_JqeQyTCyMmtvXdmGhygaeku2hEGYHx4DdPkrIsHAkYOiMytSLvZ-35i4H_sftsN7vPyW0R9RazEPfJ3nAx-hdgGQ31y6j-V2zzB8A
  priority: 102
  providerName: ProQuest
Title Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults
URI https://link.springer.com/article/10.1007/s00430-013-0292-3
https://www.ncbi.nlm.nih.gov/pubmed/23529214
https://www.proquest.com/docview/1417061885
https://www.proquest.com/docview/1417528146
https://www.proquest.com/docview/1427012133
Volume 202
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7R7QUJQXmVhbIyEgceSpWHEzvH3Wq3BcQKoa20nCLHsauqbVI1yWH5H_xfxnYSFQqVeokjZeJM7Jl4nJn5BuCtn6CKUa69tPC5R3FB9lJhgh3iPExDKamyVRS-LpOjY_p5Ha-7PO66j3bvXZL2Sz0ku1l4Ks9WI8BuvGgLtuOAp3wE29PDH1_mg_MA9dt3zgPf47jA9s7Mf3Xy53J0w8a84R-1y87iEax6hl20ydl-2-T78udfWI53fKMdeNiZoWTq5OYx3FPlE3jg_uERl5r0FH4NKLTkyuQg1ESUBZFtU2lNzk20UU0qTS5L1V5U-GHF6UaK5jSvig1xSCMEJby9IGihi01N3n06ObR9YBu-t2cm09NEK_U34sadnJbEpWduSJ9rbmktVkj9DFaL-ergyOvKOHgSrcHGi7iBUQuURltPyBwNxkj7kjEdIF9oLSYJlywWPs-1iGWeCE5VWkSFUDljhYqew6isSvUCCC1oqiMWmWruuFMTqaJS6sQ3e0hf83QMfj-Zmewgzk2ljfNsAGe2Q57hkGdmyLNoDB-GWy4dvsdtxHu9hGSdqte4dzIIRAHn8RjeDJdRSY3nRZSqah1NHJq_rbfRhMwC7OFjdp30DRyFOHRpGNAxfOwl6RoD_2P35Z2oX8H90IqiCW7cg1Fz1arXaHA1-QS22JrhkR8EE1S2xWy2nHRKh-1svvz2Ha8eh9Pf7BskcA
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbK9gASQrxZKGAkkHgownGcxDkgxKNll7YrhLZST40cx0aV2mRpEqH9LfwG_iMz9iaAKvbWUxRlkjiZh8eemW8IecoSUDEhbZCVTAYCJuQgU5jsEBc841oL47oo7M-SyYH4fBgfbpBffS0MplX2NtEZ6rLWuEf-OhQI9BJKGb9dfA-waxRGV_sWGl4sds3yByzZmjfTj8DfZ5zvbM8_TIJVV4FAg3PSBpFEVK_QWHA9lC7Af4ks02lqQ_gYcF6SROo0VkwWVsW6SJQUJiujUpkiTUsTwWMvkU2BBa0jsvl-e_bl6xC2AMvCfNiCBRKm9j6MyjxqaYQ5YBg2zXgQ_TsRnvNuz0Vm3YS3c51cW3mq9J0XrRtkw1Q3yVW_zUd99dIt8nMAqqVnWKbQUFWVVHdtbS09wYSkhtaWLirTndZge0EigKI9LupyST0YCQUl6E4pOPFq2dDn02-f3DPgeNR0BeVHL9w5loRiWlN_O6zw6XFFfR3nkvZF6Y7WgYo0t8n8Ijhzh4yqujL3CBWlyGyURtj2HZZ0KjNCa5swXGwyK7MxYf2_z_UKCx1bcpzkA4qzY1cO7MqRXXk0Ji-HWxYeCGQd8VbP0HxlE5r8jwSPyZPhMmgzhmhUZerO08Qct2XX0fDUIfHBa-56YRlGxOHXZTwUY_Kql56_BvC_4d5fP9zH5PJkvr-X701nuw_IFe5kGFMgt8ioPevMQ3DL2uLRShkoyS9Y_X4DF3VGjw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fa9RAEF9qBRFE_O9p1RUU1BK62d0kmwcRsZ49q8WHCvfUsNnsSqFNziZB7rP4Sfx2zuxeolK8tz4dx01ym8yfndmZ-Q0hz1gKKiaVi_KKqUjChhzlGosdkpLn3Bhp_RSFzwfp3lf5cZ7MN8ivoRcGyyoHm-gNddUYPCPfiSUCvcRKJTtuVRbxZXf6ZvE9wglSmGkdxmkEEdm3yx8QvrWvZ7vA6-ecT98fvtuLVhMGIgOOShcJhQhfsXXghmhTgi8jHDNZ5mJ4MHBk0lSZLNFMlU4npky1kjavRKVtmWWVFXDbS-RyJsCpAlXK5mOsF4ONYSGBwSIFm_yQUGUBv1RgNRgmUHMeiX-3xHN-7rkcrd_6pjfI9ZXPSt8GIbtJNmx9i1wLB3409DHdJj9HyFp6hg0LLdV1RU3fNc7REyxNamnj6KK2_WkDVhhkAyi647KpljTAklBQh_6Ugjuvly19Mfv2wd8DPo_avqT86KX_js2hWOA0XA6xPj2uaejoXNKhPd3TeniR9g45vAi-3CWbdVPb-4TKSuZOZAIHwENwp3MrjXEpw7CTOZVPCBvefWFWqOg4nOOkGPGcPbsKYFeB7CrEhLwaL1kESJB1xFsDQ4uVdWiLP7I8IU_Hn0GvMVmja9v0gSbheEC7joZnHpMP_uZeEJZxRRxeXc5jOSHbg_T8tYD_LffB-uU-IVdA6YpPs4P9h-Qq9yKMtZBbZLM76-0j8M-68rHXBEqKC9a836_hSVY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reference+ranges+and+cutoff+levels+of+pneumococcal+antibody+global+serum+assays+%28IgG+and+IgG2%29+and+specific+antibodies+in+healthy+children+and+adults&rft.jtitle=Medical+microbiology+and+immunology&rft.au=Rose%2C+M+A&rft.au=Buess%2C+J&rft.au=Ventur%2C+Y&rft.au=Zielen%2C+S&rft.date=2013-08-01&rft.issn=1432-1831&rft.eissn=1432-1831&rft.volume=202&rft.issue=4&rft.spage=285&rft_id=info:doi/10.1007%2Fs00430-013-0292-3&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-8584&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-8584&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-8584&client=summon